Stamatis G, Muller S, Weinreich G, Schwarz B, et al. Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment. Eur J Cardiothorac Surg 2021 Aug 9. pii: 6345854. doi: 10.1093.
PMID: 34368849